Most Recent
Exactech settles class action over alleged faulty implants
Medical device maker Exactech has reached a settlement in a class action over alleged defective implants, following the US company's bankruptcy.
Construction PRO
Healthscope landlords agree to rent relief, as other operators express interest
Asset manager HMC Capital, which owns 11 private hospitals operated by embattled Healthscope, has reached a rent deferral deal with receivers and says other operators have expressed interest in taking up tenancy.
Healthscope secures $100m injection from CBA as receivers appointed
The Commonwealth Bank has given Healthscope a $100 million lifeline as the embattled hospital giant appoints receivers to negotiate a sale.
Construction PRO
NorthWest vows to work with Healthscope buyers as hospital group fails
Northwest Healthcare Properties REIT has promised to work with potential buyers as Healthscope -- the trust's second largest tenant -- collapses.
Court won’t bless Strongroom AI’s sale ahead of creditors meeting
Medtech start-up Strongroom AI has lost its bid for a court order blessing its proposal to sell the company to SRSPV Pty Ltd prior to a second creditors meeting.
Class action targets Queensland Health over ‘institutional racism’
A class action has been filed against the State of Queensland on behalf of First Nations people alleging inadequate healthcare and substandard medical treatment.
‘Gun to court’s head’: Judge won’t give OK to Strongroom AI’s sale proposal
A judge has refused an eleventh-hour application by administrators for Strongroom AI for court approval of a sale offer ahead of a second creditors meeting, likening the bid to “putting a gun to the court's head".
Construction PRO
Dexus entitled to have spat over Bragg Centre lease heard by court, judge says
A judge has refused to stay a lease dispute between landlord Dexus and South Australia's premium medical research centre in favour of a contractual dispute resolution mechanism, saying it would be “unjust” to deprive Dexus of a court hearing.
Sandoz moves to block Amgen’s attorneys from prosecuting patents in IP spat
Generic drug maker Sandoz wants to shield information turned up by preliminary discovery orders from the eyes of Amgen patent attorneys in a spat over cheap versions of Amgen's bone disease drugs, and says if they view the material they should be barred from prosecuting future related patents.
Amgen wants Sandoz to give up info on regulatory approval for generic Prolia, Xgeva
Biopharmaceutical company Amgen has lodged proceedings against generic maker Sandoz, calling for documents related to regulatory approval of a generic version of its top-selling bone disease treatments.